𝔖 Bobbio Scriptorium
✦   LIBER   ✦

PROUD stands tall: delayed-start studies in Parkinson's disease

✍ Scribed by Hauser, Robert A

Book ID
120391231
Publisher
The Lancet
Year
2013
Tongue
English
Weight
49 KB
Volume
12
Category
Article
ISSN
1474-4465

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Rationale for delayed-start study of pra
Rationale for delayed-start study of pramipexole in Parkinson's disease: The PROUD study
✍ Anthony H.V. Schapira; Stefan Albrecht; Paolo Barone; Cynthia L. Comella; Michae πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 112 KB

## Abstract Perhaps the most important unmet need in Parkinson's disease (PD) is the ability to slow or prevent progression of the neurodegeneration that underlies the motor and nonmotor features of this disorder. Pramipexole, a dopamine agonist used for the symptomatic treatment of PD, has demonst

Are delayed-start design trials to show
Are delayed-start design trials to show neuroprotection in Parkinson's disease fundamentally flawed?
✍ Carl E. Clarke πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 76 KB

## Abstract Considerable effort has gone into preclinical neuroprotection research in Parkinson's disease (PD) and several large clinical trials have been mounted, but no agent has been conclusively shown to be protective. The latest innovation in PD neuroprotection trial design is the delayed‐star